(Q37824616)

23 August 2017

1 reference

title

The vagus nerve and autonomic imbalance in heart failure: past, present, and future (English)

1 reference

23 August 2017

0 references

Douglas L Mann

2

0 references

author name string

Paul J Hauptman

series ordinal

1

1 reference

23 August 2017

1 March 2011

1 reference

23 August 2017

Heart Failure Reviews

1 reference

23 August 2017

16

1 reference

23 August 2017

2

1 reference

23 August 2017

97-99

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-010-9222-2

23 August 2017

0 references

cites work

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

The problem of non-response to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Long term vagal stimulation in patients with advanced heart failure First experience in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9222-2

Evidence for impaired vagus nerve activity in heart failure

21 January 2018

1 reference

12 December 2020

Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure

1 reference

12 December 2020

Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.

1 reference

12 December 2020

Arrhythmias and vagus nerve stimulation

1 reference

12 December 2020

Vagus nerve stimulation in experimental heart failure

1 reference

12 December 2020

Methods of assessing vagus nerve activity and reflexes.

1 reference

12 December 2020

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation

1 reference

12 December 2020

Pharmacologic modulation of parasympathetic activity in heart failure

1 reference

12 December 2020

Histopathology of the stimulated Vagus nerve: primum non nocere

1 reference

12 December 2020

10.1007/S10741-010-9222-2

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21191650